Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1420 ARTÍCULOS , VIENDO DEL 196 AL 210

Brain PET in the era of anti-amyloid-β antibody therapy for Alzheimer disease

Ishii K.

Jpn J Radiol. 2026 Aug;44(8):1356-1367. doi: 10.1007/s11604-026-01998-4. Epub 2026 Apr 25.

Guiding approaches to studying Alzheimer's disease: a scoping review of community engagement, health communication, and implementation science research

Yelton B, Workman L, Schaurer L, Riccardi N, McCollum Q, Belza B, Ory MG, Thorpe RJ, Wheeler SB, Trinh-Shevrin C, Kreps GL, Langa KM, Friedman DB.

Gerontologist. 2026 Jun 9;66(7):gnag056. doi: 10.1093/geront/gnag056.

Development and validation of a novel single molecular immunology assay for detection of p-Tau181

Liu M, Li X, Fang H, Miao D.

J Alzheimers Dis. 2026 Jul;112(2):797-805. doi: 10.1177/13872877261453031. Epub 2026 May 20.

A systematic review on the effects of hypercaloric diet in animal models of Alzheimer's disease

Carbone E, Scibetta S, Cappella M, Crestini A, Perrone F, Hallulli M, Rosa P, Rivabene R, Maiolo F, Simonelli V, Ricceri L, Di Bari MA, De Luca G, Vanacore N, Lacorte E, Piscopo P.

J Alzheimers Dis. 2026 Jul;112(2):576-610. doi: 10.1177/13872877261448495. Epub 2026 May 22.

Revisiting butyrylcholinesterase in Alzheimer's disease: A hub linking cholinergic, metabolic and affective pathways

Svobodova B, Soukup O, Korabecny J.

Ageing Res Rev. 2026 Jul;119:103187. doi: 10.1016/j.arr.2026.103187. Epub 2026 May 25.

Mesenchymal stem cell-mediated regulation of neuroinflammation and amyloid-β clearance: A promising therapeutic strategy for Alzheimer's disease

Wang Y.

J Alzheimers Dis. 2026 Jul;112(2):531-542. doi: 10.1177/13872877261451894. Epub 2026 May 27.

Comparative long-term outcomes of home-based versus institutional care in Alzheimer's disease

Tan Y, Liu Q, Wu C, Zhang C, Yao Q, Li J, Kang Y, Huang B, Gu L, Lu J, Zhu D, Sun M.

J Alzheimers Dis. 2026 Jul;112(1):483-499. doi: 10.1177/13872877261451155. Epub 2026 May 29.

A century of coffee and tea research in cognitive health and Alzheimer's disease: Structural, thematic, and translational insights (1911-2025)

Taha MME, Abdelwahab SI, Sahli KA, Jeraiby M, Qadri M, Alarifi A, Farasani A, Moshi JM.

J Alzheimers Dis. 2026 Jul;112(1):452-470. doi: 10.1177/13872877261450996. Epub 2026 May 30.

Ultrasound-induced blood-brain barrier opening in Alzheimer's disease: a systematic review of clinical studies

Niknam N, Songhori N, Nekahi N, Kavian M, Khosravi F, Fard AM, Moshiri Y, Haghshenas N, Sadegh MH, Torabi P.

Aging Clin Exp Res. 2026 Jun 2;38(1):171. doi: 10.1007/s40520-026-03408-1.

Linguistic-cognitive intervention in a case of early-onset Alzheimer's disease

Souza BA, Freitas MID.

Codas. 2026 Jun 1;38(3):e20250126. doi: 10.1590/2317-1782/e20250126pt. eCollection 2026.

GGAs: Regulation of Multiple Sorting Pathways and Potential Association With Human Diseases

Wang Q, Mei J, Li S, Zhang G, Qiu J, Li X.

J Cell Mol Med. 2026 Jun;30(11):e71215. doi: 10.1111/jcmm.71215.

Cascaded deep learning enables multimodal brain PET spatial normalization and quantification for Alzheimer's disease

Tang C, Tang A, Wan M, Li C, Ruan W, Liu F, Fang H, Gai Y, Jiang D, Zhou W, Lan X, Sun X; Alzheimer’s Disease Neuroimaging Initiative.

Neuroimage. 2026 Sep;338:122039. doi: 10.1016/j.neuroimage.2026.122039. Epub 2026 Jun 6.

The Use of Statins in Parkinson's and Alzheimer's Disease: A 2021-2025 State-of-the-Art Review of Clinical and Preclinical Evidence

Chiatto LM, Buccarello L, Carota G, Calabrò RS, Rifici C, Esposito E, Ardizzone A, Caruso G.

Pharmacol Res Perspect. 2026 Jun;14(3):e70280. doi: 10.1002/prp2.70280.

Targeting inflammaging in Alzheimer's disease: molecular pathways and emerging pharmacotherapies

Alotaibi MO, Al-Kuraishy HM, Fahad EH, Abdelaziz AM, El-Saber Batiha G.

Inflammopharmacology. 2026 Jul;34(7):4445-4461. doi: 10.1007/s10787-026-02281-8. Epub 2026 Jun 8.

Repurposing antidiabetics for Alzheimer's disease and related neurodegenerative disorders: Translational challenges and role of nanoparticle-mediated CNS targeting

Alnsour L, Al-Samydai A, Sadek B, Akour A.

Biomed Pharmacother. 2026 Jul;200:119614. doi: 10.1016/j.biopha.2026.119614. Epub 2026 Jun 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias